Pericellular Innervation of Neurons Expressing Abnormally Hyperphosphorylated Tau in the Hippocampal Formation of Alzheimer's Disease Patients by Blazquez-Llorca, Lidia et al.
Frontiers in Neuroanatomy  www.frontiersin.org  June 2010  | Volume 4  | Article 20  |  1
NEUROANATOMY
Original research article
published: 24 June 2010
doi: 10.3389/fnana.2010.00020
and the entorhinal cortex (Hyman et al., 1984; Price et al., 1991; 
Morrison and Hof, 2002). NFT are first observed in the transen-
torhinal and entorhinal cortex, and incipiently in CA1 (stages I 
and II; transentorhinal stages), before these regions become more 
extensively affected and NFT appear in the subiculum at stages III 
and IV (the limbic stages). Finally, the main feature of stages V and 
VI is the development of abundant NFT in neocortical association 
areas (isocortical stages).
NFT accumulation is thought to be highly specific since there 
are areas where tangles are relatively infrequent, such as the pre- 
and parasubiculum or the dentate gyrus (Hyman et al., 1984, 1986; 
Arendt et al., 1998; Braak et al., 2006). According to their affinity for 
silver staining methods (Alzheimer, 1911) or by applying specific 
immunocytochemical techniques, various morphologically sub-
types of NFT have been described (Bancher et al., 1989; Braak et al., 
1994; Braak and Braak, 1995; reviewed in Tolnay and Probst, 1999; 
Shimazaki et al., 2005). However, three main subtypes have general 
been reported that seem to correspond to various evolutionary 
stages of the lesions. The earliest stage is termed the pre-tangle stage 
and it is characterized by the accumulation of PHF-tau protein in 
the somatodendritic domain of affected neurons. These neurons 
are non-argyrophilic and therefore, they can only be detected with 
anti-PHF-tau antibodies. The next stage involves the appearance of 
classic intracellular NFT, while in the final stage ghost NFT accu-
mulate, defined as NFT located “freely” in the neuropil with no 
IntroductIon
In  the  brain  of  patients  with  Alzheimer’s  disease  (AD)  the 
microtubule-associated protein tau is abnormally hyperphos-
phorylated or abnormally phosphorylated on sites that are not 
found in normal adult human tau isolated from postmortem 
brain samples (Matsuo et al., 1994). In this state, tau is the major 
protein subunit of the paired helical filaments (PHF) that form 
neurofibrillary tangles (NFT), a hallmark of this disease (Kidd, 
1963; Brion et al., 1985; Grundke-Iqbal et al., 1986; Kosik et al., 
1986; Goedert and Spillantine, 2006). In AD brains, PHF-tau not 
only accumulates in NFT (Grundke-Iqbal et al., 1986) but also in 
the cytosol, mixed with other diffusely scattered abnormal fibers 
(Iqbal et al., 1986; Bancher et al., 1989). This diffuse cytoplas-
mic PHF-tau reactivity has been postulated to reflect an altered 
neuronal state that precedes the formation of compacted NFT 
(Tolnay and Probst, 1999).
NFT were first described ultrastructurally in the 1960s, showing 
them to be bundles of abnormal cytoplasmic filaments that accu-
mulate in nerve cell bodies and their processes (Kidd, 1963, 1964; 
Terry, 1963; Terry et al., 1964; reviewed in Goedert and Spillantine, 
2006). It was subsequently shown that the manner in which neurofi-
brillary lesions appear follows a stereotypical pattern that has been 
used to define six neuropathological stages (Braak and Braak, 1991, 
1995; Braak et al., 2006; Alafuzoff et al., 2008). In general, the most 
strongly affected cortical areas are the CA1 field, the subiculum 
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relationship to a neuronal soma (Bancher et al., 1989; Braak et al., 
1994). Both, classical and ghost NFT are easily identified with silver 
staining techniques.
NFT seem to specifically affect certain neuronal types (Braak 
and Braak, 1987; Braak et al., 1989; Iwamoto and Emson, 1991; 
Hyman and Gomez-Isla, 1994; Morrison et al., 1998; Braak et al., 
2000). For example, most PHF-tau-immunoreactive (-ir) neurons 
in the neocortex and hippocampal formation are relatively large 
pyramidal neurons, whereas spiny stellate cells, small pyramidal 
cells, as well as non-spiny interneurons are reported to be remark-
ably resistant to neurofibrillary lesions (Hirano and Zimmerman, 
1962; Mountjoy et al., 1983; Pearson et al., 1985; Braak and Braak, 
1986; Braak et al., 1989). However, the appearance of NFT in par-
ticular neurochemical types of non-pyramidal cells has also been 
highlighted (Roberts et al., 1985; Iwamoto and Emson, 1991). It is 
thought that neurons that contain NFT may survive for decades 
but probably with functional deficits (Braak et al., 2006). However, 
as far as we know there are no studies addressing the synaptic 
innervation of different types of PHF-tau-ir cells. Thus, one of 
the main goals of the present study was to examine the changes 
to the pericellular innervation of PHF-tau-ir neurons in the hip-
pocampal formation and adjacent cortex of AD patients.
Since NFT seem to affect mainly pyramidal neurons, it is impor-
tant to remember that different portions of the pyramidal cell are 
innervated by different types of GABAergic interneurons (Houser 
et al., 1984; DeFelipe and Farinas, 1992; Jones, 1993; Freund and 
Buzsaki, 1996; Somogyi et al., 1998). For example, double-bouquet 
cells innervate the dendritic spines and shafts of apical collat-
eral branches and the basal dendrites of pyramidal neurons. By 
contrast, basket cells innervate the soma and proximal dendrites, 
and chandelier cells innervate the axon initial segments, two cell 
types that are thought to exert a strong influence on the output 
of pyramidal cells. In particular, chandelier cells are thought to 
control the generation and back propagation of action poten-
tials, as well as participating in complex activities such as the syn-
chronization of firing patterns in large populations of pyramidal 
cells in different states of consciousness (see Miles et al., 1996; 
Klausberger et al., 2004; Cobb and Davies, 2005; Howard et al., 
2005). In addition, dendritic spines and shafts represent the only 
postsynaptic sites on pyramidal cells that establish synapses with 
axon terminals forming asymmetric glutamatergic (excitatory) 
synapses (Bourne and Harris, 2007; Spruston 2008). However, both 
glutamatergic and GABAergic terminals are typically found in the 
perisomatic region, although only GABAergic terminals establish 
axo-somatic synapses (Alonso-Nanclares et al., 2004; Merchan-
Perez et al., 2009). Nevertheless, the tight spatial association of 
excitatory  axo-dendritic  synapses  with  axo-somatic  inhibitory 
terminals around the perisomatic regions of pyramidal cells has 
recently been proposed to be responsible for the non-synaptic 
glutamatergic interactions observed in electrophysiological and 
pharmacological studies (Ren et al., 2007), probably due to neu-
rotransmitter spillover (Merchan-Perez et al., 2009).
Since in patients at different stages of the disease, the number 
of neurons that express PHF-tau in different cortical areas is very 
variable, we simply set out to study the perisomatic innervation 
of  these  neurons  independent  of  the  individual  pathological 
  characteristics. Therefore, we used dual   immunocytochemistry and 
confocal   microscopy reconstructions to examine the   distribution 
of GABAergic and glutamatergic axon terminals in the periso-
matic region and proximal processes of PHF-tau-ir pyramidal 
cells. Accordingly, in these cells we studied the distribution of the 
GABA transporter 1 (GAT-1: Minelli et al., 1995; DeFelipe and 
Gonzalez-Albo, 1998), the vesicular GABA transporter (VGAT: 
Chaudhry et al., 1998; Dumoulin et al., 1999; Minelli et al., 2003) 
and the vesicular glutamate transporter 1 (VGLUT-1: Ni et al., 
1996; Bellocchio et al., 1998; Fremeau et al., 2001; Kaneko and 
Fujiyama, 2002; Varoqui et al., 2002; Alonso-Nanclares et al., 
2004). In addition, antibodies against the calcium binding protein, 
parvalbumin (PV), were used to examine whether PHF-tau-ir 
pyramidal neurons are innervated by specific types of axon ter-
minals from GABAergic interneurons, especially since PV immu-
nocytochemistry has been shown to label a subpopulation of 
GABAergic neurons that include basket cells and chandelier cells 
(DeFelipe et al., 1989). Furthermore, we examined to what extent 
PV-ir neurons were affected by neurofibrillary lesions. Finally, 
there is very little information regarding the perisomatic innerva-
tion of PHF-tau-ir neurons at the ultrastuctural level. Indeed, it 
is possible that innervation of PHF-tau-ir pyramidal neurons is 
affected and that this innervation varies according to the type of 
neurofibrillary alteration. Thus, we used a correlative light and 
electron microscopy method to examine the perisomatic synapses 
around PHF-tau-ir neurons.
MaterIals and Methods
Human brain tissue was obtained at autopsy from two sources: 
from eight patients with AD [aged 80–94: 84 ± 7, mean ± standard 
deviation (SD)]; and from control human brain tissue from seven 
individuals (aged 23–69: 53 ± 17, mean ± SD) who died in an acci-
dent and were free of any neurological or known psychiatric illness 
(Table 1). The AD brain tissues were obtained from the Instituto 
de Neuropatología (Dr. I. Ferrer, Servicio de Anatomía Patológica, 
IDIBELL-Hospital Universitario de Bellvitge, Barcelona, Spain) 
and from the Banco de Tejidos Fundación CIEN (Dr. A. Rábano, 
Área de Neuropatología, Centro Alzheimer, Fundación Reina Sofia, 
Madrid, Spain). The control human brains were obtained from 
the Servicio de Patología Forense (Dr. R. Alcaraz, Instituto Vasco 
de Medicina Legal, Bilbao, Spain). Following a neuropathologi-
cal examination, the AD stages were defined according to Braak 
and Braak (1991: Table 2). Control cases (C1–C7) were associated 
with different scores for the amyloid and neurofibrillary pathol-
ogy. While C1 and C5–C7 had a Braak score of zero for both 
pathologies, C2–C3 had a small number (+) of PHF-tau-ir neu-
rons, whereas C4 had many (+++). Finally, while C2 developed 
numerous (+++) plaques immunostained for Aβ, there were no 
such plaques in cases C3–C4 (see Figures 4 and 8). In all cases, 
the time between death and tissue processing was between 1.5 and 
3 h, and the brain samples were obtained following the guidelines 
and approval by the Institutional Ethical Committee. The tissue 
from these human brains has been used in previous studies (e.g., 
Arellano et al., 2004).
Upon removal, the brain tissue was immediately fixed in cold 
4% paraformaldehyde in phosphate buffer (PB: 0.1 M, pH 7.4), 
and after 2 h, the tissue was cut into small blocks and post-
fixed in the same fixative for 24–48 h at 4°C. After fixation, all Frontiers in Neuroanatomy  www.frontiersin.org  June 2010  | Volume 4  | Article 20  |  3
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Table 1 | Summary of case data.
  Age  Gender  Postmortem delay (h)  Cause of death
AD PATieNTS
P1  80  Female  2  –
P2  94  Female  1.5  Pulmonary tuberculosis
P3  82  Female  3  Pneumonia
P4  80  Female  3  Pseudomembranous colitis + sepsis 	
	 		 	 +  pancreatic adenocarcinoma
P5  85  Male  2  Pneumonia + interstitial pneumonitis
P6  88  Female  2  Bronchopneumonia
P7  91  Male  3  Hepatocarcinoma
P8  72  Male  2  Bronchopneumonia
CoNTrol CASeS
C1  23  Male  2-3  Traffic accident
C2  49  Male  2-3  Traffic accident
C3  69  Male  2-3  Traffic accident
C4  63  Female  3  Traffic accident
C5  59  Male  1.5-2  Traffic accident
C6  40  Male  3  Traffic accident
C7  66  Male  3  Traffic accident
Table 2 | Neuropathological assessment of the accumulation of NFT (immunostained for PHF-tau) and plaques (immunostained for Aβ). The overall 
amount of NFT and Aβ is graded and labeled zero (0) where no discernible change is detected, (+) with a small, (++) moderate and (+++) large amount of NFT 
or Aβ.
Cortical areas                 
examined  Patients  P1  P2  P3  P4  P5  P6  P7  P8
  Diagnosis  AD iV/B  AD V/C  AD iii/B  AD iii (TAD*)  AD iii/A  AD iii (TAD*)   AD iii/A  AD i (TAD*)   
            and AGD  and AGD  and AGD  and AGD
Entorhinal region  PHF-tau  +++  +++  +++  +++  +++  +++  +++ 0
outer layers  Aβ  +  +  ++  0  0  0  0  0
Entorhinal region  PHF-tau  +++  +++  +++  +++  ++  +++  +++ 0
inner layers  Aβ  +  +  ++  0  0  0  0  0
Hippocampus  PHF-tau  +++  +++  ++  ++  ++  ++  0  0
 A β  +  +  0  0  0  0  0  0
Transentorhinal  PHF-tau  +++  +++  +++  +++  +++  +++  +++  ++
region  Aβ  ++  ++  ++  0  0  0  + 0
Occipito-temporal  PHF-tau  NA  +++  ++  +++  +++  ++  ++ 0
region (areas 36)  Aβ  NA  ++  ++  0  +  0  + 0
Temporal cortex  PHF-tau  NA  NA  0  0  0  0  0  0
(area 22)  Aβ  NA  NA  +  0  0  0  0  0
Frontal cortex  PHF-tau  NA  +++  0  0  0  0  0  0
(area 8)  Aβ  NA  +++  ++  0  0  0  + 0
Occipital cortex  PHF-tau  NA  +++  0  0  0  +  0  0
(area 17)  Aβ  NA  +++  +  0  0  0  0  0
Occipital cortex  PHF-tau  NA  +++  0  0  0  0  0  0
(areas 18/19)  Aβ  NA  +++  +  0  +  0  0  0
AGD, argyrophilic grain disease; NA, material not available; TAD*, tangle-predominant variant of Alzheimer’s disease. AD staging follows the nomenclature of Braak 
and Braak (1991).
the specimens were immersed in graded sucrose solutions and 
they were stored in a cryoprotectant solution at −20°C. Serial 
sections (50 μm) of the cortical tissue were obtained using a 
vibratome, and the sections from each region and case were 
batch-processed for immunocytochemical staining. The sections 
immediately adjacent to those stained immunocytochemically 
were Nissl-stained in order to identify the cortical areas and the 
laminar boundaries.Frontiers in Neuroanatomy  www.frontiersin.org  June 2010  | Volume 4  | Article 20  |  4
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the sections were treated with Autofluorescence Eliminator Reagent 
(2160, Chemicon) to reduce lipofucsin like-autofluorescence with-
out adversely affecting other fluorescent labeling in the sections.
To examine the pericellular innervation of PHF-tau-ir neurons, 
some sections were double stained with a mixture of antibodies 
GAT-1/PHF-tau, VGAT/PHF-tau, PV/PHF-tau, or VGLUT-1/PHF-
tau. The same primary antibodies, dilutions, and incubation times 
as indicated above were used. Free-floating sections were incubated 
overnight at 4°C in a solution containing the primary antibodies 
and then for 2 h at room temperature with a biotinylated goat 
anti-rabbit antibody for GAT-1/PHF-tau, VGAT/PHF-tau, and PV/
PHF-tau, or in a biotinylated goat anti-guinea pig antibody for 
VGLUT-1/PHF-tau (1:200: Vector). After rinsing in PB, the sec-
tions were incubated for 2 h at room temperature with streptavidin 
coupled to Alexa fluor 488 (1:2,000, S-32354,  Molecular Probes) 
and with Alexa fluor goat-anti mouse 594. After rinsing in PB, the 
sections were treated with Autofluorescence Eliminator Reagent.
Finally, the sections were washed and mounted with ProLong 
Gold Antifade Reagent (Invitrogen Corporation, Carlsbad, CA, 
USA), and they were examined on a LeicaDMI 6000B confocal laser 
scanning system equipped with an argon/krypton mixed gas laser 
with excitation peaks at 488 and 594 nm. The fluorescence of Alexa 
488 and 594 was recorded through separate channels. We obtained 
both single optical sections and image stacks (z-step 0.14 μm) that 
consisted of 19–43 image planes. Both 40× oil-immersion (NA, 
1.25, refraction index, 1.52) and 63X oil-immersion (NA, 1.40, 
refraction index, 1.52) lens were used, in some cases with a calcu-
lated optimal zoom factor 3.2.
QuantItatIve and statIstIcal analyses
A BX51 Olympus microscope equipped with a motorized stage and 
the Neurolucida package (MicroBrightField, Williston, VT, USA) 
was used to estimate the density of PHF-tau-ir neurons with dif-
ferent patterns of staining. Using the Neurolucida package, the 
hippocampal formation and adjacent cortex were traced in con-
tiguous Nissl-stained sections with the 4× objective, and the com-
plete surface of the previously defined counting fields was scanned 
with a 40× objective in successive and non-overlapping frames of 
17,250 μm2. All the PHF-tau-ir neurons were recorded and classified 
as displaying a type I or II immunostaining pattern (see Results). In 
Table 3, the areas of the cortical regions examined in each control 
and AD patient cases are shown.
To estimate the number of perisomatic GABAergic terminals 
around PHF-tau-ir neurons and around neurons that do not accu-
mulate PHF-tau, we quantified the number of VGAT-ir boutons 
associated with these neurons in the CA1 field and the supragranular 
layers of the parahippocampal gyrus (PHG; which includes entorhi-
nal and perirhinal cortex) in sections from AD patient P7 stained 
for VGAT/PHF-tau. In this way, such comparisons could be used 
as internal controls to eliminate the effects of age and pathological 
progression. We chose brain sections from patient P7 because the 
immunostaining was of the best quality. Moreover, to minimize 
possible differences due to cellular variability, we selected neurons 
(n = 20 per immunocytochemical pattern of staining and cortical 
region) with similar somatic parameters. Sections were examined 
on a Zeiss LSM 710 confocal laser scanning microscope and single 
optical sections (physical size 67.41 μm × 67.41 μm, logical size 
IMMunohIstocheMIstry
Free-floating sections were pre-treated in 1% H2O2 for 30 min to 
remove endogenous peroxidase activity, and subsequently they 
were blocked for 1 h in PB with 0.25% Triton-X and 3% normal 
goat or horse serum (for polyclonal antisera and monoclonal anti-
bodies, respectively: Vector Laboratories Inc., Burlingame, CA, 
USA). Single immunohistochemistry was performed with the 
following polyclonal antisera and monoclonal antibodies: GABA 
transporter 1 (GAT-1, 1:500, AB1570: Chemicon International, 
Temecula, CA, USA); vesicular GABA transporter (VGAT, 1:2,000, 
131003: Synaptic Systems, Goettingen, Germany); vesicular gluta-
mate  transporter  1  (VGLUT-1,  1:5,000,  AB5905:  Chemicon); 
parvalbumin (PV, 1:1,000, AB11427: Abcam, Cambridge, United 
Kingdom); and an anti-human PHF-tau monoclonal antibody 
(clone AT8, 1:100, MN1020: Thermo Scientific; Waltham, MA, 
USA).  This  anti-PHF-tau  antibody  has  been  shown  to  detect 
PHF-tau doubly phosphorylated (we shall refer to as PHF-tau) at 
both Ser202 and Thr205 (Porzig et al., 2007). The sections were 
incubated overnight at 4°C with the antibodies described above 
and the following day, the sections were rinsed and incubated 
for 2 h with biotinylated goat anti-rabbit IgG (1:200, BA-1000: 
Vector Laboratories) (GAT-1, VGAT and PV immunostaining), 
biotinylated goat anti-guinea-pig IgG (1:200, BA-7000: Vector 
Laboratories) (VGLUT-1 immunostaining) or biotinylated horse 
anti-mouse IgG (1:200, BA-2000: Vector Laboratories) (PHF-tau 
immunostaining) antibodies. The sections were then incubated 
for 1 h in an avidin–biotin peroxidase complex (Vectastain ABC 
Elite PK6100, Vector), and finally with the 3,3′-diaminobenzidine 
tetrahydrochloride chromogen (DAB: Sigma-Aldrich, St. Louis, 
MO, USA). After staining, the sections were dehydrated, cleared 
with xylene and coverslipped. In addition, adjacent sections to 
those stained for PHF-tau were processed immunocytochemically 
as above to visualize amyloid beta (Aβ) plaques using a mouse 
antibody against Aβ (clone 6F/3D 1:50, M0872: Dako, Glostrup, 
Denmark). Control sections were processed as above but without 
the primary antibodies and no significant staining was seen under 
these conditions. Furthermore, to rule out possible false positive 
staining as a consequence of the AT8 antibody recognizing non-
phosphorylated tau rather than the hyperphosphorylated tau at 
high concentrations, we carried out an experiment with serial 
dilutions of this PHF-tau antibody up to 1:20,000. We observed a 
progressive decrease in the staining intensity of all the elements. 
No separate elements ceased staining at different dilutions and no 
staining was observed at dilutions above 1:10,000.
dual fluorescence IMMunohIstocheMIstry and 
hIstocheMIstry
To ascertain the relationship between neurons immunocytochemi-
cally stained for PHF-tau and neurons histochemically labeled for 
Thioflavine-S to visualize NFT, some sections were stained using 
the same anti-PHF-tau antibody at the dilutions and incubation 
times indicated above. Thereafter, the sections were incubated for 
2 h at room temperature with the Alexa fluor conjugated goat-anti 
mouse 594 antibody (1:2,000, A-11005, Molecular Probes, Eugene, 
OR, USA). After rinsing the sections in PB, they were incubated for 
10 min in a 1% solution of Thioflavine-S and they were then rinsed 
for 5 min in 100%, 70% and then 50% ethanol. After rinsing in PB, Frontiers in Neuroanatomy  www.frontiersin.org  June 2010  | Volume 4  | Article 20  |  5
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the light microscope and then photographed to locate the region 
of interest. Selected semithin sections were further sectioned into 
serial ultrathin sections (50–70 nm thick) with a diamond knife 
using a Reichert ultramicrotome. The ultrathin sections were col-
lected on formvar-coated single-slot nickel grids, and stained with 
uranyl acetate and lead citrate. Digital pictures were captured at 
different magnifications in a Jeol 150 transmission electron micro-
scope (JEOL USA, Inc., MA, USA) equipped with a SIS Megaview 
III CCD digital camera.
results
a note on the noMenclature of the huMan 
hIppocaMpal regIons
The hippocampus proper (Cornu Ammonis fields) is commonly 
subdivided into the CA1, CA2, CA3, and CA4 fields, according to 
the nomenclature of Lorente de Nó (1934). Ammon’s horn neurons 
within the granule cell layer constitute the CA4 field. However, as 
pointed out by Insausti and Amaral (2004), the absence of clear 
cytoarchitectonic features or connections that distinguish CA3 
neurons from those of the CA4 make it more convenient to con-
sider these fields simply as the CA3, thereby including the neu-
rons of Ammon’s horn in this region. Thus, for the sake of clarity 
we denominate this region CA3/CA4. In addition, we will use the 
nomenclature of Insausti and Amaral, (2004) when considering 
the hippocampal formation and adjacent cortex: dentate gyrus 
(DG); hippocampus proper (CA1, CA2, and CA3/4); subicular 
complex (subdivided in subiculum [Sub], presubiculum [preS], 
parasubiculum [paraS]); entorhinal cortex (EC); perirhinal cortex 
(PRC); and posterior parahippocampal cortex (PPC). Finally, CA1 
was subdivided into three equal portions: proximal, medial, and 
distal with respect to the DG.
dIstrIbutIon and staInIng pattern of phf-tau-Ir neurons
We studied the distribution and pattern of PHF-tau-ir neurons, 
and their relationship with Aβ plaques, in order to obtain more 
detailed information on the pathological characteristics of the dif-
ferent patients examined.
Using a variety of silver and immunohistochemical staining 
techniques, the pathological changes of the immunoreactive neu-
rons were classified and a morphological series was established to 
reflect the sequence of changes believed to be experienced by the 
individual nerve cell as the disease progresses (Braak et al., 1994). 
1024 × 1024 pixels) were obtained with a 63× oil-immersion lens 
(NA, 1.40, refraction index, 1.45) and an optical zoom factor 2.0. 
Because of the limited penetration of the antibodies in the sec-
tions, the images were taken from the superficial part of the section 
(2–3 μm in depth from the surface). Using the Neurolucida 7.1 
Confocal module (MicroBrightfield, Inc., Williston, VT, USA), it was 
possible to draw and calculate the perimeter of the cells and mark 
the labeled boutons around them. After drawing the perimeter, the 
red channel of the confocal microscope system (which corresponded 
to PHF-tau staining) was removed to carry out a blind study of the 
perisomatic innervation. The results are presented as the number of 
VGAT-ir boutons per 100 μm of the somatic perimeter and the data 
are presented as the mean ± SD. Statistical comparisons were carried 
out with the aid of GraphPad Prism statistical package (Prism, San 
Diego, CA, USA). A two-way analysis of variance (ANOVA), fol-
lowed by Bonferroni post-test were used to analyze the differences in 
the number of VGAT-ir boutons around the three types of neurons 
(PHF-tau-negative, type I and II PHF-tau-ir) in the different regions 
(CA1 field and parahippocampal gyrus).
Finally, the proportion of PV-ir neurons that were also labeled 
for PHF-tau was estimated in at least two sections from the hip-
pocampal formation of four patients (P1, P3, P4, and P7), and in 
that of a single control (C7), all of which were processed for dual 
fluorescence immunohistochemistry. These sections were exam-
ined on a BX51 Olympus fluorescence microscope.
electron MIcroscopy
Sections adjacent to those used for histopathological assessment 
and some sections immunostained for PHF-tau were processed 
for electron microscopy. Immunohistochemistry for PHF-tau fol-
lowed the same protocol as that laid out above, except that the 
pre-treatment in 1% H2O2 only lasted for 10 min and Triton-X 
was excluded from the buffers. Once the immunohistochemical 
staining had been completed, the sections were post-fixed in 2% 
glutaraldehyde in PB for 1 h, treated with 1% osmium tetroxide for 
40 min, dehydrated and flat embedded in Araldite resin. Plastic-
embedded sections were studied using correlative light and electron 
microscopy as described in detail elsewhere (DeFelipe and Fairen, 
1993). Briefly, sections were photographed under the light micro-
scope and then serially cut into semithin (2 μm thick) sections 
with a Reichert ultramicrotome. The semithin sections were stained 
with 1% toluidine blue in 1% borax, they were examined under 
Table 3 | Total areas (mm2) analyzed in control and AD patients.
  C1  C2  C3  C4  C6  P1  P3  P4  P6  P7
PPC    43.4  22.8        39.8  20.7   
PRC        22.3    7.4      12.1  36.3
EC  20.0      19.2    23.5      13.1  23.0
ParaS    9.5    4.8      9.6  10.0  7.3  3.9
PreS  9.1  20.1  13.2  5.5    8.9  6.7  8.7  7.2  5.8
S  9.5  7.6  6.6  7.7    8.7  7.8  10.9  6.7  13.7
CA1  45.2  15.9  24.5  17.1  17.1  49.6  23.7  16.9  13.1  17.3
CA2    1.2  1.9  1.0  0.9    1.3  1.0  0.8  1.3
CA3/4    6.4  8.7  8.7  6.5  1.5  7.3  6.7  6.2  9.4
DG    1.3  1.1  3.1  1.5  5.1  2.7  1.9  1.6  3.9Frontiers in Neuroanatomy  www.frontiersin.org  June 2010  | Volume 4  | Article 20  |  6
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et al. (1989) and Group 1–2 of Braak et al. (1994), while type II 
corresponds to Stage 2–3 of Bancher et al. (1989) and Group 3–5 
of Braak et al. (1994). The type I pattern was characterized by 
the diffuse cytoplasmic staining (with no NFT: Figures 2 and 3) 
of neurons with a normal morphology, but with dendrites and 
proximal axons that were often strongly stained, displaying Golgi-
like labeling. In neurons with a type II pattern, the amount of 
somatic cytoplasm occupied by the NFT varied (Figures 2 and 3). 
The   dendritic arbor of the neurons had relatively little NFT and 
In general, early stages are characterized by abnormal delicate fibril-
lary inclusions within affected neurons. These fibers aggregate into 
large bundles that finally fill the entire neuronal cytoplasm as clas-
sic NFT. In the present work, we classified PHF-tau-ir neurons as 
type I or II, based on previous studies (Bancher et al., 1989 and 
Braak et al., 1994). In sections immunocytochemically stained with 
the anti-PHF-tau antibody, numerous neurons were labeled in all 
cortical areas of the hippocampal formation and adjacent cortex 
examined (Figure 1). Type I corresponds to Stage 0–1 in Bancher 
FiGure 1 | Hippocampal formation from patient P7 immunostained for PHF-tau. (A) Low-power photomicrograph. (B–F) Photomicrographs illustrating different 
areas of the hippocampal formation: hilus of the dentate gyrus [DG] (B), CA2 (C), CA1 (D), subiculum [S] (e), and entorhinal cortex [EC] (F). Scale bar: 1.8 mm in  
(A); 170 μm in (B–F).Frontiers in Neuroanatomy  www.frontiersin.org  June 2010  | Volume 4  | Article 20  |  7
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was found in control tissue than in that from AD patients in all 
the fields studied, with the exception of control case C4 in which a 
similar or higher density than in AD cases was evident in the Sub, 
CA1, and CA2. The density of PHF-tau-ir neurons varied consider-
ably between different AD patients. For example, while patient P1 
was diagnosed at AD stage IV (the most severe stage of all the cases 
studied), this patient only had the highest density of PHF-tau-ir 
neurons in the preS when compared with the rest of the control and 
AD tissue (Figure 6A). Patient P4 had much lower densities in all 
it usually displayed numerous dendritic processes. Neurons whose 
cytoplasm was full of NFT have very few dendritic processes, sug-
gesting they were undergoing neuronal atrophy.
Since PHF-tau-ir neurons were also present in control tissue (see 
Discussion), we plotted all PHF-tau-ir neurons in the hippocampal 
formation and adjacent cortex from both control (Figure 4) and 
AD patients (Figure 5). Moreover, we quantified the density of 
PHF-tau-ir neurons with type I and II staining in the different 
regions (Figure 6). In general, a lower density of PHF-tau-ir cells 
FiGure 2 | High-power microphotographs to illustrate the 
morphological appearance of PHF-tau-ir neurons. (A) Pyramidal neuron 
from the CA1 field of control case C2. (B,C) Pyramidal neurons from the CA2 
field of patients P4 and P3, respectively. (D) Pyramidal neuron from the 
entorhinal cortex of patient P1. (A–C) Correspond to pattern I of PHF-tau 
staining, which is characterized by a diffuse cytoplasmic staining and the 
neurons display a normal morphology. (D) Correspond to pattern II of PHF-tau 
staining, which is characterized by the presence of NFT. These neurons 
appear to have fewer processes probably due to neuronal atrophy. Scale 
bar:  37 .5 μm.Frontiers in Neuroanatomy  www.frontiersin.org  June 2010  | Volume 4  | Article 20  |  8
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neurodegenerative disorders, including AD, particularly in the DG 
(Thal et al., 2005; Ferrer et al., 2008; Josephs et al., 2008). Thus, the 
high density of PHF-tau-ir neurons in the DG in cases P6 and P7 
might be explained by the co-existence of AGD.
The distribution by layers revealed that both in control and AD 
tissue, the highest density of PHF-tau-ir neurons was found in lay-
ers II-III and occasionally in layer V of the PPC, PRC, and EC. In 
CA1, CA2, CA3/4, and DG, virtually all PHF-tau-ir neurons were 
located in the pyramidal layer of the CA fields and in the granular 
layer of the DG (Figure 6).
the hippocampal fields than P3, P6, and P7 patients, even though 
each was considered as stage AD III (Table 2). In addition, patients 
P6 and P7 showed a relatively high density of PHF-tau-ir neurons 
in the DG even though granular cells do not typically develop neu-
rofibrillary lesions (Braak and Braak, 1991). Interestingly, these 
two patients also suffered from argyrophilic grain disease (AGD), 
which is a neurodegenerative disease often associated to other neu-
rodegenerative disorders and that is characterized by the presence 
of argyrophilic grains in several cortical regions. It has been sug-
gested that AGD may enhance the pathological alterations in several 
FiGure 3 | Confocal microscopy of sections double stained with 
an anti-PHF-tau antibody (red) and Thioflavine-S (TS, green), which 
labels PHF-tau forming NFT. (A,B), (D,e), (G,H), and (J,K) pairs of 
confocal images from the same section and field in the CA1 hippocampal 
region of AD patient P1, P7 , P4, and P3, respectively. Panels (C,F,i,l) were 
obtained by combining these images (A) and (B), (D) and (e), (G) and  
(H), (J) and (K), respectively. Note that type I PHF-tau-ir neurons  
(one asterisk) were free of NFT, whereas type II neurons (two asterisks) 
contained NFT (arrows). Scale bar: (A–C), 21 μm; (D–F), 24 μm;  
(G–l), 31.5 μm.Frontiers in Neuroanatomy  www.frontiersin.org  June 2010  | Volume 4  | Article 20  |  9
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dual IMMunofluorescence studIes
Since the main objective of this study was to examine the peri-
somatic innervation of neurons showing different patterns of 
PHF-tau staining, irrespective of the neuropathological stage 
of the patient, we used dual immunofluorescence to determine 
whether the expression of PHF-tau induced or was related to 
any changes in the affected neurons. While it is well-established 
that only GABAergic terminals form axo-somatic synapses with 
pyramidal cell bodies, both glutamatergic and GABAergic termi-
nals are typically found in the perisomatic region (Merchan-Perez 
et al., 2009). For this reason, we used dual immunofluorescence 
to label GABAergic (GAT-1, VGAT, and PV) and glutamatergic 
(VGLUT-1) axon terminals and to examine the innervation in 
the perisomatic region, proximal dendrites, and axon initial 
segment of PHF-tau stained neurons in different cortical areas 
(PPC, PRC, EC, paraS, preS, Sub, CA1, CA2, CA3/4, and DG) in 
tissue from control and AD patients. Control cases were simply 
used to verify that postmortem factors did not alter the staining 
The percentage of neurons displaying type I staining increased 
from the adjacent cortex of the hippocampal formation (PPC or 
PRC and EC) towards the DG, with the highest proportion of these 
neurons found in the field CA3/4 (Figure 7). The widest variabil-
ity of these neurons was observed in the DG: 76% of neurons in 
case P3 and 78% of neurons in case P6 displayed type I staining, 
whereas in P7 and C4 (control case) this figure was 41 and 24%, 
respectively (Figure 7).
Finally, adjacent sections stained for PHF-tau were processed 
to visualize Aβ plaques to find out whether the density and dis-
tribution of PHF-tau-ir neurons was related to the density of Aβ	
plaques in tissue from both control (Figure 8) and AD patients 
(Figure 9). Comparing the distribution of PHF-tau-ir neurons 
and Aβ plaques revealed no such correlation since there were 
regions where the density of both PHF-tau-ir neurons and Aβ	
plaques was very high whereas in other regions a high density of 
PHF-tau-ir neurons coincided with a region with few Aβ plaques 
and vice versa.
FiGure 4 | Drawings based on Neurolucida plots made with a 40× 
objective to illustrate the distribution of PHF-tau-ir neurons displaying type 
i (blue dots) and type ii (red dots) patterns of staining in the hippocampal 
formation and adjacent cortex from control cases. Borders between the 
different cytoarchitectonic regions are indicated by arrowheads. Scale bar: 
1,000 μm. Abbreviations as in Figure 5.Frontiers in Neuroanatomy  www.frontiersin.org  June 2010  | Volume 4  | Article 20  |  10
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GABAergic innervation of PHF-tau-ir cells
The  pericellular  staining  of  GAT-1,  VGAT,  and  PV  around 
PHF-tau-ir neurons was similar to that found around PHF-tau-
negative cells from both control and AD tissue. For example, we 
examined the innervation of the soma and proximal dendrites 
by GAT-1 and VGAT-ir terminals of PHF-tau-ir cells with type 
I staining in detail (n =  364). Normal innervation was appar-
ent in all the regions studied and the perisomatic innervation was 
indistinguishable between PHF-tau-ir cells and PHF-tau-negative 
cells (Figures 10A–F). Remarkably, innervation of the soma and 
proximal dendrites by GAT-1-ir and VGAT-ir axon terminals was 
of the perisomatic terminals typically described in experimen-
tal animals and human biopsy tissue (e.g., Alonso-Nanclares 
and DeFelipe, 2005; Merchan-Perez et al., 2009). Indeed, the 
staining pattern of perisomatic terminals was identical to that 
published previously in both experimental animals and human 
biopsy tissue. Thus, we considered that the human tissue used 
here was suitable for the purpose of the study. Because of the 
limited penetration of the antibodies, we only studied those 
PHF-tau-ir cells that were situated in the superficial part of 
the section where both GABAergic and glutamatergic terminals 
could be clearly labeled.
FiGure 5 | Drawings based on Neurolucida plots made with a 40× 
objective showing the distribution of PHF-tau-ir neurons showing type i 
(blue dots) and type ii (red dots) staining in the hippocampal formation 
and adjacent cortex from AD cases. Borders between the 
different cytoarchitectonic regions are indicated by arrowheads. Scale  
bar: 1,000 μm.Frontiers in Neuroanatomy  www.frontiersin.org  June 2010  | Volume 4  | Article 20  |  11
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Similarly, the axon initial segment innervated by GAT-1 and 
VGAT stained chandelier terminals also appeared unaltered in 
PHF-tau-ir cells displaying type I (n =  10 cells) or II staining 
(n = 14 cells; Figures 12A–F).
To further study the pericellular innervation of PHF-tau-ir 
cells,  we  also  used  dual  immunofluorescence  for  PV  and 
PHF-tau. It is well-established that PV-ir neurons represent a 
apparently intact even in PHF-tau-ir neurons displaying the type 
II pattern (n =  382 cells, Figure 11). To quantify these obser-
vations, we estimated the number of VGAT-ir boutons around 
PHF-tau-ir and PHF-tau negative neurons (Figures 10J,K) in two 
regions (CA1 field and PHG) of patient P7. As shown in Table 4, 
the number of perisomatic terminals did not differ significantly 
around PHF-tau-ir and PHF-tau negative neurons.
FiGure 6 | (A) Graphs showing the density of PHF-tau-ir neurons with type I 
and II staining in control and AD patients in different regions of the hippocampal 
formation and adjacent cortex: granular layer of dentate gyrus (DG); pyramidal 
layer of hippocampus proper (CA1, CA2, and CA3/4); pyramidal layer of 
subiculum (S), presubiculum (preS), parasubiculum (paraS), entorhinal cortex 
(EC), perirhinal cortex (PRC), and posterior parahippocampal cortex (PPC).  
(B–e) Graphs showing the density of PHF-tau-ir neurons with type I and II 
staining in control and AD patients in the different layers of the PRC, PPC, and 
EC, and in the pyramidal cell layer of the distal, medial and proximal portions of 
CA1, respectively.Frontiers in Neuroanatomy  www.frontiersin.org  June 2010  | Volume 4  | Article 20  |  12
Blazquez-Llorca et al.   PHF-tau-immunoreactive neurons
FiGure 7 | Graphs showing the percentage of PHF-tau-ir neurons displaying 
type i and ii staining in the hippocampal formation and adjacent cortex of 
control and AD patients. Dentate gyrus (DG); CA3/4, CA2, CA1 proximal 
(CA1 Prox), CA1 medial (CA1 Med), CA1 Distal (CA1 Dist), subiculum (S), 
presubiculum (preS), parasubiculum (paraS) and parahippocampal gyrus (PHG) that 
includes the entorhinal cortex, perirhinal cortex, or posterior parahippocampal cortex.
FiGure 8 | Drawings based on Neurolucida plots made with a 40× 
objective showing the distribution of diffuse, cored neuritic, and non-cored 
neuritic plaques (red, green, and blue circles, respectively; see Garcia-Marin 
et al., 2009) in the hippocampal formation and adjacent cortex from control 
cases. Borders between the different cortical cytoarchitectonic regions are 
indicated by arrowheads. Abbreviations as in Figure 5. Scale bar: 1,000 μm.Frontiers in Neuroanatomy  www.frontiersin.org  June 2010  | Volume 4  | Article 20  |  13
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in CA3/4; 396 in CA1; 1120 in Sub; and 2342 in EC), only two 
cells were PHF-tau-ir (one in the stratum oriens and one in 
CA3/4). Thus, GABAergic innervation of the soma, proximal 
dendrites and axon initial segments apparently remains unal-
tered in AD patients.
Glutamatergic terminals around PHF-tau-ir cells
We studied the distribution of VGLUT-1-ir glutamatergic axon 
terminals around PHF-tau-ir cells and like the innervation of 
GABAergic terminals, the distribution of the VGLUT-1-ir axon 
terminals was also apparently normal around PHF-tau-ir cells. 
We examined PHF-tau-ir cells showing a type I (n = 95 cells) and 
large subpopulation of cortical GABAergic interneurons that 
includes basket and chandelier cells (DeFelipe, 1993). These cells 
provide the main GABAergic innervation to the soma, proximal 
dendrites and axon initial segments of pyramidal cells. We again 
found that the innervation of the soma and the axon initial 
segment of type I and II stained PHF-tau-ir cells by PV-ir axon 
terminals  (basket  and  chandelier  terminals)  was  apparently 
unaltered (Figures 12G–I and 13). In addition, the vast major-
ity of PV-ir cells did not contain PHF-tau (Figures 13A–C and 
G–I). To quantify this observation, we counted the number of 
PV-ir neurons that were also PHF-tau-ir in the hippocampal 
formation. Of the 3943 PV-ir neurons analyzed (36 in DG; 49 
FiGure 9 | Drawings based on Neurolucida plots made with a 40× 
objective showing the distribution of diffuse, cored neuritic and non-cored 
neuritic plaques (red, green, and blue circles, respectively; see Garcia-Marin 
et al., 2009) in the hippocampal formation and adjacent cortex from AD cases. 
Borders between the different cortical cytoarchitectonic regions are indicated by 
arrowheads. Abbreviations as in Figure 5. Scale bar: 1,000 μm.Frontiers in Neuroanatomy  www.frontiersin.org  June 2010  | Volume 4  | Article 20  |  14
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electron MIcroscopy
The ultrastructure of PHF-tau-ir neurons and the surrounding 
neuropil was examined using correlative light and electron micros-
copy (DeFelipe and Fairen, 1993). Briefly, 100 μm thick plastic sec-
tions containing type I or II stained PHF-tau-ir neurons were first 
II (n = 103 cells) pattern in detail, comparing them to the periso-
matic innervation observed on neurons with no PHF-tau in control 
tissue or that from AD patients. Again the perisomatic innervation 
appeared to be similar around PHF-tau-ir and negative neurons 
(Figures 10G–I).
FiGure 10 | (A,B), (D,e) (G,H), pairs of confocal images from the same 
section and field showing the distribution of GABAergic (VGAT-ir and GAT-1-ir) 
and glutamatergic (VGLUT-1-ir) perisomatic axon terminals (green) around the 
cell body of PHF-tau-negative neurons and PHF-tau-ir neurons with type I 
staining (red) in the CA2 of patient P7 (A,B), CA1 of patient P7 (D,e), and 
CA1 of patient P3 (G,H). Arrows indicate some type I PHF-tau-ir neurons. 
Panels (C,F) and (i) were obtained by combining images (A) and (B), (D) and 
(e), and (G) and  (H), respectively. (J),(K), high magnification confocal 
images from the  entorhinal cortex of patient P7 to illustrate perisomatic 
VGAT-ir boutons around PHF-tau-negative neurons (asterisk in (J)) and pattern 
I (J) and pattern II PHF-tau-ir neurons (K). Scale bar: (A–C), 67 μm; (D–i), 
43 μm; (J,K), 9 μm.Frontiers in Neuroanatomy  www.frontiersin.org  June 2010  | Volume 4  | Article 20  |  15
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from those of neurons that did not appear to contain PHF-tau. 
As a consequence, we considered these neurons to be normal 
(Figures 14C,D). Nevertheless, the preservation of the tissue was 
not optimal and as such we were unable to analyze the ultrastruc-
ture of the cytoplasm in greater detail. Hence, it remains possible 
that these neurons suffer some alterations in their cytoplasm that 
passed unnoticed.
We also examined 21 neurons displaying type II PHF-tau staining. 
In these neurons abnormally hyperphosphorylated PHF-tau formed 
NFT of PHF arranged in relatively large bundles that were packed into 
the cytoplasm of the soma and proximal dendrites. These bundles 
were often so large and densely packed that cytoplasmic organelles 
were completely replaced with these PHF-tau-ir bundles. That is, the 
regions of the soma or dendrites that contained these bundles were 
cut into 2 μm semithin sections. Thereafter, selected 2 μm semithin 
sections were cut into ultrathin sections for electron microscopy. In 
this way, it was possible the systematically and accurately localize 
the stained cells and surrounding neuropil in the successive steps 
of the procedure (Figure 14).
A total of 16 neurons displaying type I PHF-tau staining were 
studied by correlative light and electron microscopy and bun-
dles of PHF-tau filaments did not appear to be present in these 
neurons at the light microscopy or ultrastructural level. Rather, 
the PHF-tau staining in their cytoplasm consisted of an electron 
dense granular deposition formed by small particles that were 
responsible for the homogeneous brownish staining observed 
under the light microscope. Other ultrastructural characteris-
tics of the cytoplasm in the labeled cells were indistinguishable 
FiGure 11 | (A,B), (D,e), pairs of confocal images from the same section and 
field to illustrate the presence of GAT-1-ir axon terminals (green) around the cell 
bodies of PHF-tau-ir neurons with type II staining (red) in the entorhinal cortex 
(A–C) and subiculum (D–F) of patients P7 and P1, respectively. Panels (C) and 
(F) were obtained by combining images (A) and (B), and (D) and (e), 
respectively. Scale bar: 20 μm.
Table 4 | Comparison of the number of VGAT-immunoreactive perisomatic boutons per 100 μm of the perimeter (mean ± SD) of PHF-tau-negative 
neurons, and of type i and ii PHF-tau-ir neurons, in CA1 field and parahippocampal gyrus (PHG; that includes the entorhinal and the perirhinal 
cortex) of patient P7.
region    PHF-tau-negative  Pattern i PHF-tau-ir   Pattern ii PHF-tau-ir 
CA1  Nº terminals  8.92 ± 4.51  6.76 ± 2.50  6.97 ± 2.90
  Total perimeter length  1,459 μm  1,503 μm  1,473 μm
PHG  Nº terminals  13.07 ± 4.00  11.49 ± 4.20  12.70 ± 4.29
  Total perimeter length  1,366 μm  1,320 μm  1,471 μm
No significant differences were observed.Frontiers in Neuroanatomy  www.frontiersin.org  June 2010  | Volume 4  | Article 20  |  16
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dIscussIon
There  were  three  main  findings  from  the  present  study.  First, 
we observed two main patterns of PHF-tau staining in neurons, 
type I and II patterns, the distribution of which varies accord-
ing to the cortical layer and area. Second, the distribution of both 
GABAergic and glutamatergic terminals around the soma and 
proximal processes of PHF-tau-ir neurons does not seem to be 
altered, and it is indistinguishable from that in control tissue or in 
adjacent neurons that do not contain PHF-tau. Third, at the elec-
tron microscope level, neurons with type I PHF-tau staining did 
not develop bundles of PHF-tau filaments and the cytoplasm was 
apparently normal. However, PHF-tau in type stained II neurons 
formed NFT of PHF arranged in large bundles that were packed 
basically lacking other elements or cytoplasmic organelles. However, 
the rest of the cytoplasm that was not occupied by these abnormal 
bundles was apparently unaltered (Figures 14E–G).
Finally, when we analyzed the neuropil surrounding PHF-tau-ir 
neurons it had a normal aspect, and no reactive glial processes 
nor abnormal looking dendrite or axonal profiles were observed. 
Furthermore,  the  typical  symmetric  synapses  innervating  the 
somata of pyramidal cells were preserved on the PHF-tau-ir neu-
rons with either type I or II staining. In addition, in the neuropil 
adjacent to these cells normal looking symmetric and asymmetric 
synapses were also observed (Figures 14H–J and 15). These obser-
vations suggest that the synaptic connectivity around these neurons 
was apparently unaltered.
FiGure 12 | (A,B), (D,e), (G,H), pairs of confocal images from the same 
section and field to illustrate chandelier cell axon terminals (arrowhead) 
around the axon initial segment (arrow) of PHF-tau-ir neurons (red) with 
type ii staining in the CA1 field (A,B) and subiculum (D,e) of patient P3, and 
in CA1 of patient P7 (G,H). Panels (C), (F), and (i) were obtained by combining 
images (A) and (B), (D) and (e), and (G) and (H), respectively. Chandelier cell 
axon terminals were labeled using antibodies against VGAT, GAT-1 or PV (green). 
Scale bar: 43 μm.Frontiers in Neuroanatomy  www.frontiersin.org  June 2010  | Volume 4  | Article 20  |  17
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adjacent cortex in control and AD cases. Thus, we cannot com-
pare these results with those from previous studies. It seems likely 
that type I staining is due to the accumulation of unpolymerized 
PHF-tau whereas the type II pattern is due to the accumulation 
of polymerized PHF-tau into NFT. Whether pattern I represents 
a pre-tangle stage and therefore precedes pattern II, or if this 
just occurs in a subpopulation of these neurons representing an 
independent stage is unclear. The amount of somatic cytoplasm 
occupied by NFT in type II stained neurons is rather variable. 
Since there are clearly fewer labeled dendritic processes in neurons 
with more NFT, it seems that atrophy progresses as type II stained 
neurons accumulate NFT. However, further studies using intrac-
ellular injection of Lucifer Yellow, for example, or other markers 
into the cytoplasm of the soma and proximal dendrites. Normal 
looking symmetric and asymmetric synapses were also observed 
in the adjacent neuropil.
dIstrIbutIon of phf-tau-Ir neurons In the hIppocaMpal 
forMatIon and adjacent cortex
In general, the percentage of type I and II PHF-tau-ir neurons 
in the hippocampal formation and adjacent cortex was similar 
between the different patients (except in CA2 and the DG), and 
there were numerous PHF-tau-ir neurons in both AD patients and 
in control tissue from some individuals. As far as we know, this is 
the first attempt to quantify the distribution of different patterns 
of PHF-tau staining in the human hippocampal   formation and 
FiGure 13 | (A,B), pairs of confocal images (stacks of 10 optical sections; 
step size: 1.04 μm) to illustrate that PV-ir axon terminals (green) are preserved 
around the somata of PHF-tau-ir neurons (red) in CA1 (patient P7). (D,e), pairs 
of single confocal sections showing an PHF-tau-ir pyramidal cell (also indicated 
in (A) with an arrow) to illustrate its perisomatic innervation by PV-ir axon 
terminals at higher magnification. (G,H), pairs of single confocal sections 
showing three PV-ir neurons (arrowhead), none of them are labeled for 
PHF-tau. Panels (C), (F), and (i) were obtained after combining images (A) and 
(B), (D) and (e), and (G) and (H), respectively. Scale bar: (A–C), 67 μm; 
(D–i), 43 μm.Frontiers in Neuroanatomy  www.frontiersin.org  June 2010  | Volume 4  | Article 20  |  18
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to visualize the complete dendritic arbor of the neurons will be 
necessary to ascertain whether neurons with type II staining have 
fewer dendritic branches than those showing a type I pattern. 
Whatever the relationship between the type I and II pattern, these 
observations further emphasize that neurons selectively accumu-
late PHF-tau in a region dependent manner, either as NFT or in 
the unpolymerized form.
Most affected neurons in regions other than the DG can 
be recognized as pyramidal neurons as would be expected 
given the large number of neurons affected and the fact that 
these neurons represent the vast majority of cortical neurons. 
However, PV-ir neurons were rarely PHF-tau-ir and they repre-
sent a large subpopulation of GABAergic interneurons (Celio, 
1986; DeFelipe, 1993; Burkhalter, 2008). Although we cannot 
FiGure 14 | Correlative light and electron microscopy of PHF-tau-ir 
neurons in the pyramidal layer of CA1 from patient P1. (A) Photomicrograph 
of a plastic-embedded 100 μm-thick section immunostained for PHF-tau.  
(B) Photomicrograph of a 2-μm-thick semithin section stained with 1% toluidine 
blue obtained from the section shown in (A). (C), (F), higher magnification of 
cells 1 (pattern I of PHF-tau-immunostaining) and 7 (pattern II of PHF-tau-
immunostaining), respectively, also shown in (A) and (B). (D), (e,G), electron 
micrographs of neurons 1 and 7 , respectively, obtained after the resectioning of 
the semithin section shown in (B). The cytoplasm of neuron 1 (D) has a normal 
appearance, whereas the cytoplasm of neuron 7 (G) and (e) has NFT of paired 
helical filaments stained for PHF-tau (asterisks in e and i). (H,i,J) Electron 
micrographs illustrating the neuropil around PHF-tau-ir cells. Arrows indicate 
some normal looking synaptic contacts situated in close proximity of the 
PHF-tau-ir cell bodies which have been pseudo-colored in blue. Scale bar:  
(A), 104 μm; (B), 95 μm; (C,F), 23 μm; (D), 1.5 μm; (e), 1.1 μm; (G), 10 μm;  
(H), 0.6 μm; (i), 0.8 μm; (J), 0.5 μm.Frontiers in Neuroanatomy  www.frontiersin.org  June 2010  | Volume 4  | Article 20  |  19
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cells are not homogeneous throughout the cerebral cortex of AD 
patients. For example, the subpopulation of PV-ir cells apparently 
remains unaltered in the prefrontal and inferior temporal cortex 
(Hof et al., 1991) and in the temporal cortex (Ferrer et al., 1991), 
whereas PV-ir cells appear to be more vulnerable in the hippocam-
pal formation of AD patients (Brady and Mufson, 1997). Indeed, a 
60% decrease in the number of PV-ir interneurons was observed in 
the DG/CA4, CA1 and CA2 but not in the CA3, Sub or preS (Brady 
and Mufson, 1997). A loss of PV-ir neurons in different layers of 
the EC has also been reported (Solodkin et al., 1996; Mikkonen 
et al., 1999).
A decrease in PV-ir chandelier terminals has been described 
in layer II of the temporal cortex (Fonseca et al., 1993), as well 
as a decrease in the intensity of PV staining in the neuropil 
(Solodkin et al., 1996). However, this decrease in PV-ir termi-
nals was thought to be related to the loss of the pyramidal target 
neurons rather than to a loss of PV-ir neurons. Nevertheless, 
the relationship between the PV-ir presynaptic terminals and 
their postsynaptic targets, either PHF-tau-ir or negative, has 
yet not been studied specifically. Thus, one of the goals of 
this study was to examine the pericellular innervation and the 
neuropil surrounding PHF-tau-ir neurons. We did not observe 
any loss of GABAergic or glutamatergic axon terminals around 
the soma of PHF-tau-ir neurons. The fact that the presynap-
tic terminals of basket and chandelier cells were still present 
around type I PHF-tau-ir neurons was expected as these neu-
rons look normal. However, the innervation of type II PHF-
tau-ir neurons by these terminals was more surprising since 
many of these neurons are atrophied. Therefore, it seems that 
the connections between GABAergic basket/chandelier cells 
and PHF-tau-ir neurons remain unaltered. Furthermore, our 
study shows that PV-ir interneurons rarely express PHF-tau in 
the hippocampal formation of different types of AD patients, 
supporting the idea that this subpopulation of GABAergic cells 
is in general well preserved. However, alterations in the syn-
aptic connections may exist at the molecular or physiological 
level, and further studies on animal models will be necessary 
to resolve this question.
Finally, the discrepancy observed between different laborato-
ries regarding the loss or preservation of GABAergic neurons may 
be explained by differences in tissue processing, in the methods 
of analysis (quantitative versus qualitative studies), and/or in the 
postmortem delay, together with the clinical variability between 
patients and control tissue.
sIgnIfIcance of phf-tau
One of the striking findings in relation to the neuropathological 
aspects of AD is the fact that abundant Aβ plaques and/or NFT 
may also be found in non-demented elderly and young control 
individuals. Thus, there is a poor correlation between the degree 
of cognitive impairment and the presence of Aβ plaques and 
NFT, in accordance with other pathological findings such as neu-
ronal loss (Crystal et al., 1988; Katzman et al., 1988; Price et al., 
1991; Arriagada et al., 1992; Dickson et al., 1992; see Price et al., 
2009 for a recent study). Indeed, in the present study, two of 
the seven control cases (C2 and C4) displayed dense accumula-
tions of Aβ plaques or PHF-tau-ir neurons, respectively. Thus, 
rule out that PV/PHF-tau-ir neurons are lost by cell death, it 
seems unlikely given the preservation of the basket and chan-
delier axon terminals that originate from neurons expressing 
PV (see below), even in cortical regions with abundant NFT. 
Thus, basket and chandelier cells are unaffected by tau patholo-
gies. In addition, pyramidal cells located in different cortical 
regions and layers of the hippocampal formation and adjacent 
cortex project to different targets (Insausti and Amaral, 2004; 
Duvernoy, 2005). Since the density of PHF-tau-ir pyramidal 
neurons varies in function of both the cortical region and corti-
cal layer, this further emphasizes that the malfunction of synap-
tic circuits in which PHF-tau-ir neurons participate is probably 
very specific (see also Lewis et al., 1987; Hof and Morrison, 
1990; Hof et al., 1990, 1995; Arnold et al., 1991; Gomez-Isla 
et al., 1996; reviewed in Morrison and Hof, 2007).
perIcellular InnervatIon of phf-tau-Ir neurons
At both the confocal and ultrastructural levels, the perisomatic 
distribution of glutamatergic and GABAergic terminals apparently 
remains unaltered in all PHF-tau-ir neurons studied in the dif-
ferent hippocampal regions examined. Although only GABAergic 
terminals establish axo-somatic synapses, both glutamatergic and 
GABAergic terminals are typically found in the perisomatic region 
(Merchan-Perez et al., 2009). This is in line with other studies 
suggesting that GABAergic circuits in the cerebral cortex of AD 
patients are relatively well preserved when compared to circuits 
that use other neurotransmitters (Young, 1987; Lowe et al., 1988; 
Reinikainen et al., 1988; Ferrer et al., 1991; Hof et al., 1991; Nägga 
et al., 1999; Bell et al., 2003; Rissman et al., 2007). However, other 
studies indicated possible alterations to the PV-ir basket and chan-
delier cells in the cerebral cortex of AD patients that are responsi-
ble for the GABAergic pericellular innervation of pyramidal cells 
(DeFelipe et al., 1989; reviewed in Jones, 1993; Freund and Buzsaki, 
1996; DeFelipe, 1999). In general, it seems that alterations to PV-ir 
FiGure 15 | High magnification electron micrograph illustrating the 
neuropil around the PHF-tau-ir cell 7 also shown in Figure 14, where the 
soma has been pseudo-colored in blue. Asterisk, paired helical filaments 
stained for PHF-tau. Arrows indicate some synaptic contacts in the neuropil. 
Scale bar: 0.5 μm.Frontiers in Neuroanatomy  www.frontiersin.org  June 2010  | Volume 4  | Article 20  |  20
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ing Aβ plaques, the loss of dendritic spines and the thinning of 
dendritic shafts passing through Aβ plaques. Therefore, the loss 
or morphological alteration of spines provoked by Aβ plaques in 
the neuropil may be related to local alterations, mostly to axo-
spinous glutamatergic synapses. Furthermore, we recently found 
that neurons in contact with Aβ plaques appear to be normal 
at the ultrastructural level in the APP/PS1 mouse model of AD, 
although the membrane of the neuronal somata in contact with 
the Aβ plaque lacked GABAergic axo-somatic synapses in both the 
APP/PS1 mouse and in AD patients (Garcia-Marin et al., 2009). In 
addition, the portion of the soma of these neurons that was not in 
contact with the Aβ plaques established typical synapses, whereas 
synapses are absent from the region in direct contact with the Aβ 
plaques. Thus, direct contact of the Aβ plaque with the cell body 
does not induce perisomatic disconnection further away from 
the contact domain. Based on these findings, we proposed that 
dendrites are more susceptible to the toxic effect of Aβ than the 
cell body, which should clearly have important consequences on 
cortical circuits. Furthermore, we found a significant decrease in 
the frequency of large spines in Aβ plaque-free regions of the DG 
in the APP/PS1 mice model of AD (Knafo et al., 2009a,b). Because 
large spines are considered to be the physical traces of long-term 
memory (Kasai et al., 2003; Bourne and Harris, 2007), a widespread 
decrease in the frequency of large spines probably contributes to 
the cognitive impairments observed in this AD model. Whether 
this also occurs in AD patients is not yet known, although partial 
GABAergic disconnection at the level of the somata of neurons in 
contact with the Aβ plaques has been shown to occur both in the 
mice model of AD and in AD patients. Since the distribution of 
Aβ plaques and PHF-tau-ir neurons coincided in some regions but 
not in others, their local densities are rather variable and they have 
different impact on microcircuits. Thus, to better understand the 
correlation between the presence of Aβ plaques and NFT with cog-
nitive impairment, this relationship should be studied in greater 
detail, at the level of the microanatomical changes that occur in 
the different cortical regions of AD patients.
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the   development of Aβ plaques and NFT seems to be a natural 
aging process in certain individuals, although it is greatly exac-
erbated or accelerated in AD.
There is some controversy about the significance of the intra-
cellular accumulation of NFT (for a recent review see Hernandez 
and Avila, 2008). Initially, it was thought that the presence of 
NFT was intimately linked to cell death and areas that were more 
severely damaged reflected the areas with more NFT in the human 
hippocampal formation (Hyman et al., 1984). These areas were 
the Sub, layer II and layer IV of the EC. It was proposed that the 
presence of NFT is associated with impaired axonal transport 
which would culminate in neuronal death (Stamer et al., 2002; 
Terwel et al., 2002; Cente et al., 2006; Smith et al., 2007). However, 
NFT accumulation might represent a compensatory strategy (at 
least initially) to protect neurons against oxidative stress or toxic 
cytosolic PHF-tau (Alonso Adel et al., 2006; Nunomura et al., 
2006; Hernandez and Avila, 2007; Iqbal et al., 2008). Studies on 
transgenic mouse models have demonstrated that the presence 
of NFT does not necessarily lead to cell death, and it was shown 
that neuronal loss in the DG preceded the formation of NFT 
(Spires et al., 2006). In addition, NFT were found in the striatum 
without any evidence of neuronal loss. In the same mouse model, 
caspase activation occurs in neurons containing NFT indicative of 
apoptotic death (Spires-Jones et al., 2008). However, this caspase 
activation seems to be insufficient to cause acute neuronal death as 
these neurons do not express either morphological or biochemi-
cal changes typically found in classical apoptosis. Thus, it was 
proposed that forming NFT could be an anti-apoptotic strategy 
that would delay neuronal death even after caspase activation 
(Spires-Jones et al., 2008).
relatIonshIp between tauopathIes and synapses
Irrespective of whether PHF-tau-ir neurons finally die or not, their 
perisomatic innervation seems to be unaltered. In other words, 
it seems that these perisomatic axons do not degenerate, nor are 
they eliminated by glial phagocytosis (“synaptic stripping”: see 
Blinzinger and Kreutzberg, 1968; Moran and Graeber, 2004) due 
to the expression of PHF-tau, at least at the stages of the disease 
examined  in  the  present  work.  In  addition,  a  normal  looking 
neuropil with typical symmetric and asymmetric synapses were 
also observed in the neuropil adjacent to these cells. However, we 
cannot conclude that the normal activity of the cell is not com-
promised. That is, we do not know if the synapses established with 
PHF-tau-ir somata and dendrites are functionally normal at the 
presynaptic level and/or at the postsynaptic level. Indeed, the den-
dritic arbor of type II stained neurons seems to be atrophied and 
thus their function must be altered even though synaptic connec-
tions are still present in the perisomatic region. Thus, PHF-tau 
accumulation could cause synaptic dysfunction in the absence of 
clear morphological changes.
Tauopathies certainly lead to cognitive decline or dementia 
in the absence of Aβ and therefore, neurofibrillary lesions may 
be sufficient to explain this cognitive decline. Thus, what is the 
contribution of Aβ plaques to this process? Aβ plaques induce 
local morphological alterations to the dendrites in contact with Aβ 
(Tsai et al., 2004; Spires et al., 2005; Knafo et al., 2009a,b). These 
alterations include the sprouting of spines on dendrites contact-Frontiers in Neuroanatomy  www.frontiersin.org  June 2010  | Volume 4  | Article 20  |  21
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